Literature DB >> 24709571

Examination of prognostic factors in patients undergoing surgery for colorectal perforation: a case controlled study.

Tetsuo Sumi1, Kenji Katsumata2, So Katayanagi3, Yuuki Nakamura3, Tomohisa Nomura3, Kiminori Takano3, Kazuhiko Kasuya2, Motohide Shimazu3, Akihiko Tsuchida2.   

Abstract

OBJECTIVE: To determine if the POSSUM, SOFA, MPI, and SAS scores provide a better measure of severity for patients with prognostic factors undergoing surgery for colorectal perforation.
SUBJECTS: Fifty-nine patients who underwent surgery between 1996 and 2012.
METHODS: We retrospectively reviewed background factors, blood and physiological test results, and intraoperative findings of patients who survived and those who died. We also compared the POSSUM, SOFA, MPI, and SAS scores. Multivariate analysis was performed for factors that were significant by univariate analysis, and selected factors were used to produce a predictive prognostic model.
RESULTS: Univariate analysis revealed significant differences in age, anticoagulant/steroid administration, serum creatinine level, PF ratio, base excess (BE), chest radiography, pulse rate, and severity of peritoneal soiling. Age, serum creatinine level, pulse rate, and severity of peritoneal soiling were selected for multivariate analysis; only pulse rate was significantly different. There were significant differences between the two groups in POSSUM PS, OSS, SOFA, and MPI scores, and a comparison in terms of the ROC curve showed that our model had the highest peak; the area under the curve was 94.8% compared with 70-80% for the other systems, suggesting that our model is better than those systems.
CONCLUSIONS: POSSUM and SOFA are valid methods of evaluating risk from colorectal perforation, but our study revealed addition risk factors: (1) the PF ratio and BE, which are not included in POSSUM; (2) the pulse rate and severity of peritonitis, which are not included in SOFA; and (3) anticoagulant/steroid hormone administration.
Copyright © 2014 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Colorectal perforation; Prognostic factor; Prognostic scoring system

Mesh:

Year:  2014        PMID: 24709571     DOI: 10.1016/j.ijsu.2014.03.021

Source DB:  PubMed          Journal:  Int J Surg        ISSN: 1743-9159            Impact factor:   6.071


  5 in total

1.  Pre and postoperative lactate levels and lactate clearance in predicting in-hospital mortality after surgery for gastrointestinal perforation.

Authors:  Min Kyu Kang; Seung-Young Oh; Hannah Lee; Ho Geol Ryu
Journal:  BMC Surg       Date:  2022-03-09       Impact factor: 2.102

2.  Association between trends in clinical variables and outcome in intensive care patients with faecal peritonitis: analysis of the GenOSept cohort.

Authors:  Ascanio Tridente; Geraldine M Clarke; Andrew Walden; Anthony C Gordon; Paula Hutton; Jean-Daniel Chiche; Paul A H Holloway; Gary H Mills; Julian Bion; Frank Stüber; Christopher Garrard; Charles Hinds
Journal:  Crit Care       Date:  2015-05-05       Impact factor: 9.097

3.  Study of the prognostic factor of the colon perforation case with the pan-peritonitis that needed emergency surgery: a single-center observational study.

Authors:  Fumiko Nakamura; Rintaro Yui; Arisa Muratsu; Kazuhito Sakuramoto; Takashi Muroya; Hitoshi Ikegawa; Yasuyuki Kuwagata
Journal:  Acute Med Surg       Date:  2019-06-06

4.  Prediction of hospital mortality after colorectal perforation surgery from inflammation-based prognostic scores.

Authors:  Kensuke Kudou; Tetsuya Kusumoto; Yuho Ebata; Sho Nambara; Yasuo Tsuda; Eiji Kusumoto; Rintaro Yoshida; Yoshihisa Sakaguchi; Koji Ikejiri
Journal:  Surg Open Sci       Date:  2022-01-26

5.  Derivation and validation of a prognostic model for postoperative risk stratification of critically ill patients with faecal peritonitis.

Authors:  Ascanio Tridente; Julian Bion; Gary H Mills; Anthony C Gordon; Geraldine M Clarke; Andrew Walden; Paula Hutton; Paul A H Holloway; Jean-Daniel Chiche; Frank Stuber; Christopher Garrard; Charles Hinds
Journal:  Ann Intensive Care       Date:  2017-09-12       Impact factor: 6.925

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.